Research and Development

AstraZeneca and MedImmune, the company’s global biologics research and development arm, have announced new Phase 3 data revealing that tralokinumab …

Figures released by NHS Scotland have revealed that the numbers of deaths from cancer are 67% higher in the poorest …

LipiDiDiet, a European project investigating “the impact of nutritional lipids on neuronal and cognitive performance in ageing, Alzheimer’s disease and …

Japanese firm Kirin Holdings has announced its intention to withdraw from a joint research collaboration with Amgen, saying it would …

Janssen has unveiled new data on Stelara (ustekinumab) in the treatment of patients with moderately to severely active Crohn’s disease …

Pfizer has released new data on its Crohn’s disease (CD) treatment Inflectra (infliximab CT-P13) which indicate that switching patients to …

Dear Colleague,

October is almost over and Halloween is just around the corner, and it’s time for another run-down of the stories …

AbbVie already know well what it’s like to have a lead candidate in the psoriasis field, after having Humira sat …

After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets …

A report commissioned by Prime Minister, Theresa May, has found that 300,000 people are leaving their positions of work after …

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

Eli Lilly released its Q3 financials and the major talking point was the announcement that the business was reviewing “strategic …

GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …

Blood-thinning drugs are commonly used to reduce stroke risk in patients with atrial fibrillation (AF) but research from the Karolinska …